Sr. Director Team Lead, US Migraine Access and Affordability

ROLE SUMMARY

Pfizer’s U.S. migraine portfolio consists of two, complimentary, treatments – NURTEC ODT and Zavzpret.  NURTEC ODT is the first and only FDA approved oral CGRP receptor antagonist that treats both acute and preventive migraine. NURTEC ODT has the opportunity to change the paradigm in migraine treatment and potentially establish a new standard of care.  Zavzpret is the first and only FDA approved, CGRP receptor antagonist nasal spray, that is designed to provide patients fast relief from a migraine attack with just one spray. Zavzpret launched one year ago and continues to be a launch growth brand within our portfolio.

Over 40 million patients in the U.S. currently suffer from migraine but less than 25% seek care.  About 1.2 million migraine patients visit the ER per year and almost 80% of them never sought care from a community HCP before going to the ED.  Migraine creates a significant economic burden to the U.S. healthcare system, costing over $78B annually.

Pfizer has made significant investments in the migraine portfolio and these two brands are core growth brands within Primary Care.  Nurtec ODT has been identified as a priority blockbuster product that will need to deliver significant growth in the coming years within a very competitive market. 

The Sr. Director TL will lead/manage the access and affordability strategies and execution across the Migraine franchise to support the organization’s expectations. This leader will collaborate effectively with the US Market Access, Specialty Access Solutions, Global Health and Social Impact, Field Access Liaison and Brand Management teams to optimize the franchise’s access and affordability to meet brand objectives, patient needs and commercial goals.

ROLE RESPONSIBILITIES

• Lead the development of access and affordability-related strategies and tactics in partnership with Specialty Access Solutions (SAS), U.S. Market Access (USMA), and other Pfizer cross-functional colleagues for the Migraine portfolio. This includes leadership of/involvement in payer contracting strategy, access pull through, copay offers for commercially insured patients, HUB and other access and affordability levers
• Partner with USMA, Field Force Leadership, Access Teams, FAL and PAC organization and other relevant internal stakeholders to identify opportunities to develop and/or optimize HCP and patient understanding of market access including the insurance approval and appeals process.
• Collaborate with U.S. Market Access Team to understand individual payer access strategies for Commercial, Medicare, and Medicaid and manage the impact to patient access and affordability strategies and tactics.
• Collaborate regularly with Finance to manage forecast, GTN and overall financial impact of reimbursement strategy decisions, making strategic decisions and implementing changes in real time
• Facilitate alignment of product strategies, pricing, and pull and push-through of access opportunities and barriers
• In collaboration with Brand team and Field Sales, lead the development of market access pull-through resources and tools for HCPs and Consumers
• Partner with analytics team on market access landscape reports to assess performance and summarize status of product access to field sales and brand leadership
• Proactively monitor and collaboratively identify ways to manage GTN over the course of the brand lifecycle.
• Understand and anticipate the implications of changing market dynamics.
• Continually track and optimize copay offer terms, pharmacy buy down program business rules, balancing Rx abandonment with financial metrics
• Conduct periodic competitive assessments of competitive affordability programs, patient OOP cost and actions needed to stay competitive in-patient affordability landscape.
• Partner with SAS team on the management and optimization of HUB program.
• Identify opportunities and implementing strategies in reducing access and affordability operational expenses.
• Lead team of 3 direct reports
• Ensure Migraine franchise follows SOPs and policies related to access and affordability and patient support
• Manage significant A&P budget and vendors related to affordability programs

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership capabilities including the ability to influence and collaborate with peers and develop and coach others to achieve meaningful outcomes and create business impact.

• Bachelor’s degree with a minimum 15+ years of pharmaceutical experience, MBA preferred
• In-depth knowledge of the U.S. payer landscape and reimbursement processes required, preferably with experience in products that require Prior Authorizations and Step Edits
• Knowledge of hubs, co-pay and patient ser